The North America Neurocognitive Assessment And Rehabilitation Market would witness market growth of 7.7% CAGR during the forecast period (2023-2030).
Neurocognitive assessment systematically evaluates an individual's cognitive functions, including memory, attention, language, executive functions, and sensory-perceptual abilities. This process involves a battery of standardized tests and tools designed to measure cognitive performance and identify deviations from the norm. Assessment tools may range from traditional paper-and-pencil tests to cutting-edge neuroimaging techniques, providing a comprehensive picture of an individual's cognitive health. On the other hand, neurocognitive rehabilitation involves therapeutic interventions to improve or restore cognitive functions that have been compromised due to neurological conditions, injuries, or age-related factors.
Moreover, the market is evolving, propelled by advancements in neuroscience, technology, and an increasing awareness of neurological disorders. This burgeoning field focuses on understanding and addressing cognitive impairments through a multidisciplinary approach, encompassing assessments, interventions, and rehabilitation strategies. As they delve into this dynamic landscape, it becomes evident that the intersection of neuroscience and technology unlocks unprecedented opportunities to enhance the understanding of the brain, diagnose cognitive disorders, and implement effective rehabilitation techniques.
The Centers for Disease Control and Prevention estimate that more than one in every seven adults in the United States has CKD, or approximately 35.5 million individuals, or 14%. People aged 65 or older have a higher prevalence of CKD (34%) compared to those aged 45–64 (12%) or 18–44 (6%). Early identification enables timely intervention and the implementation of strategies to address cognitive deficits before they significantly impact daily functioning. As a result, these aspects will boost market growth in the coming years.
The US market dominated the North America Neurocognitive Assessment And Rehabilitation Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $5,691.8 Million by 2030. The Canada market is experiencing a CAGR of 10.1% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 9.1% during (2023 - 2030).
Based on Component, the market is segmented into Neurorehabilitation Therapy, and Neurocognitive Assessment Testing. Based on Providers, the market is segmented into Rehab Centers, Hospital & Clinics, Homecare Settings, and Physiotherapy Centers. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Cambridge Cognition Holdings plc, Cognifit, Inc., Cogstate Ltd., Lumos Labs, Inc. (Lumosity), CNS Vital Signs, LLC, Posit Science Corporation, BrainCheck, Inc., Constant Therapy Health, NeuronUP SL and SCHUHFRIED GmbH
Neurocognitive assessment systematically evaluates an individual's cognitive functions, including memory, attention, language, executive functions, and sensory-perceptual abilities. This process involves a battery of standardized tests and tools designed to measure cognitive performance and identify deviations from the norm. Assessment tools may range from traditional paper-and-pencil tests to cutting-edge neuroimaging techniques, providing a comprehensive picture of an individual's cognitive health. On the other hand, neurocognitive rehabilitation involves therapeutic interventions to improve or restore cognitive functions that have been compromised due to neurological conditions, injuries, or age-related factors.
Moreover, the market is evolving, propelled by advancements in neuroscience, technology, and an increasing awareness of neurological disorders. This burgeoning field focuses on understanding and addressing cognitive impairments through a multidisciplinary approach, encompassing assessments, interventions, and rehabilitation strategies. As they delve into this dynamic landscape, it becomes evident that the intersection of neuroscience and technology unlocks unprecedented opportunities to enhance the understanding of the brain, diagnose cognitive disorders, and implement effective rehabilitation techniques.
The Centers for Disease Control and Prevention estimate that more than one in every seven adults in the United States has CKD, or approximately 35.5 million individuals, or 14%. People aged 65 or older have a higher prevalence of CKD (34%) compared to those aged 45–64 (12%) or 18–44 (6%). Early identification enables timely intervention and the implementation of strategies to address cognitive deficits before they significantly impact daily functioning. As a result, these aspects will boost market growth in the coming years.
The US market dominated the North America Neurocognitive Assessment And Rehabilitation Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $5,691.8 Million by 2030. The Canada market is experiencing a CAGR of 10.1% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 9.1% during (2023 - 2030).
Based on Component, the market is segmented into Neurorehabilitation Therapy, and Neurocognitive Assessment Testing. Based on Providers, the market is segmented into Rehab Centers, Hospital & Clinics, Homecare Settings, and Physiotherapy Centers. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Cambridge Cognition Holdings plc, Cognifit, Inc., Cogstate Ltd., Lumos Labs, Inc. (Lumosity), CNS Vital Signs, LLC, Posit Science Corporation, BrainCheck, Inc., Constant Therapy Health, NeuronUP SL and SCHUHFRIED GmbH
Scope of the Study
Market Segments Covered in the Report:
By Component- Neurorehabilitation Therapy
- Neurocognitive Assessment Testing
- Rehab Centers
- Hospital & Clinics
- Homecare Settings
- Physiotherapy Centers
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Cambridge Cognition Holdings plc
- Cognifit, Inc.
- Cogstate Ltd.
- Lumos Labs, Inc. (Lumosity)
- CNS Vital Signs, LLC
- Posit Science Corporation
- BrainCheck, Inc.
- Constant Therapy Health
- NeuronUP SL
- SCHUHFRIED GmbH
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. North America Neurocognitive Assessment And Rehabilitation Market by Component
Chapter 5. North America Neurocognitive Assessment And Rehabilitation Market by Providers
Chapter 6. North America Neurocognitive Assessment And Rehabilitation Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- Cambridge Cognition Holdings plc
- Cognifit, Inc.
- Cogstate Ltd.
- Lumos Labs, Inc. (Lumosity)
- CNS Vital Signs, LLC
- Posit Science Corporation
- BrainCheck, Inc.
- Constant Therapy Health
- NeuronUP SL
- SCHUHFRIED GmbH
Methodology
LOADING...
